A Novel Approach for Innovative Pharmaceutical, Nutraceutical and Biocosmeceutical Products: Different Types of Combination Products and Co-activation of Natural Synergistically Acting Target-Receptors (CanSATs)
Journal Title: Journal of Advances in Medicine and Medical Research - Year 2016, Vol 11, Issue 9
Abstract
Traditionally, the main model of the pharmaceutical industry for developing new drugs has been based on monotherapies, new molecular entities (NMEs), and their underlying one-target-one-disease dogma. It is no surprise that closely related fields such as the cosmeceutical and nutraceutical areas, largely inspired by Big Pharma, have also mainly used that model. However, compelling evidence suggests that the time has come for these sectors of R&D activities to further explore more efficient, cost-effective and reliable approaches for innovative products. Among a few approaches proposed in recent years, there is one that is of particular interest – the ‘combination drug’ often referred to as the fixed-dose combination (FDC) products approach. It has been generally defined as two or more active ingredients that are combined in a single dosage form for either new effects or superior synergistic-like efficacy with less adverse effects. Both the World Health Organization (WHO) and the U.S. Food and Drug Administration (FDA) have recognized the great potential of FDCs for the future of innovation in those sectors. In fact, the development of FDCs has recently received substantial support for commercialization of new products – that is between three and five years of additional protection and exclusivity. Next-generation FDCs have already been identified. Indeed, FDCs that may be referred to as ‘variable-dose combinations’ (VDCs) products and, more specifically, ‘Co-Activation of Natural Synergistically-Acting Target-Receptors’ (CanSATs) products when applied to natural products if synergistic-like actions are found among active ingredients. Although VDCs and CanSATs have emerged mainly from the nutraceutical and cosmeceutical sectors, these approaches may perhaps also promote the development of promising new pharmaceutical products.
Authors and Affiliations
Pierre A. Guertin
Keywords
Related Articles
- EP ID EP340429
- DOI 10.9734/BJMMR/2016/18997
- Views 62
- Downloads 0
Acute Effects of Air Stacking Versus Glossopharyngeal Breathing in Patients with Neuromuscular Disease
Objective: To compare the effects of Air Stacking (AS) and Glossopharyngeal Breathing (GPB) on the Maximum Insufflation Capacity (MIC) in patients with Neuromuscular Disease (NMD). Methods: We design a randomized cross-...
Assessing the Influence of Exposure to Violent Living Condition, Knowledge, and Personal Motivation on Human Immunodeficiency Virus Infection Prevention Behavior among Historically Black College Students
Aim: This study assesses the effects of prevention education, prevention personal motivation, prevention knowledge, and past exposure to violent living conditions on human immunodeficiency virus (HIV) infection preventio...
Neuropsychiatric Complications of Patients with Obstructive Sleep Apnea Syndrome
Objective: Patients with obstructive sleep apnea (OSA) associated with neuropsychological deficits and altered quality of life. This study aimed to assess cognitive functions, quality of life (QOL), and mood changes in p...
Bioceramic Technology in Endodontics
Bioceramics include ceramic materials specifically designed for use in medicine and dentistry. These materials are mainly alumina, zirconia, bioactive glass, glass ceramics, coatings, composites, hydroxyapatite and resor...
Impact of Oncologist Initiated Selective Review of Pathology Specimens in Multidisciplinary Onco-pathological Discussions on the Management of Malignancies in a University Hospital in India
Aim: Reported discrepancy rates after pathology review of surgical pathology specimens vary widely from 1.3% to as high as 80%. The purpose of this study was to assess the frequency of discordant diagnoses after onco – p...